Inventor
HWANG SAN-BAO
US24 patents
⚠️ This page may combine multiple inventors who share the name “HWANG SAN-BAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALTEON INC
8 patentsUS6440749B1Aug 27, 2002
Method of treating certain indications associated with hyperglycemia
ALTEON INC48 citations96
US6007865ADec 28, 1999
Reversing the formation of advanced glycosylation endproducts
ALTEON INC51 citations96
US7022719B2Apr 4, 2006
Preventing and reversing the formation of advance glycosylation endproducts
ALTEON INC7 citations74
USRE38330ENov 25, 2003
Preventing and reversing advanced glycosylation endproducts
ALTEON INC7 citations74
US5661139AAug 26, 1997
Bis-(2-aryl) hydrazones
ALTEON INC12 citations73
US5932578AAug 3, 1999
Triazine compounds and methods of use therefor
ALTEON INC3 citations62
US6380192B1Apr 30, 2002
Triazine compounds and method of use therefor
ALTEON INC0 citations52
US6060470AMay 9, 2000
Triazine compounds and methods of use therefor
ALTEON INC0 citations52
CYTOMED INC
5 patentsUS5856323AJan 5, 1999
Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
CYTOMED INC62 citations95
US5434151AJul 18, 1995
Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
CYTOMED INC89 citations95
US5358938AOct 25, 1994
Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
CYTOMED INC70 citations94
US5648486AJul 15, 1997
Compounds and methods for the treatment of inflammatory and immune disorders
CYTOMED INC55 citations92
US6294574B1Sep 25, 2001
Compounds and methods for the treatment of inflammatory and immune disorders
CYTOMED INC2 citations62
MERCK & CO INC
5 patentsUS4656190AApr 7, 1987
Indene derivatives and their use as PAF-antagonists
MERCK & CO INC26 citations92
US4595693AJun 17, 1986
Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
MERCK & CO INC45 citations92
US4539332ASep 3, 1985
2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
MERCK & CO INC43 citations92
US4704462ANov 3, 1987
Substituted 2,3,3a,6-tetrahydro-6-oxobenzofuran derivative useful as PAF antagonist
MERCK & CO INC7 citations73
US4540709ASep 10, 1985
Method for treatment of diseases mediated by PAF using 5-allyl-2-(3,4-Dimethoxyphenyl)-3a,α-methoxy-3-methyl-2,3,3a,6-tetrahydro-6-oxobenzofuran
MERCK & CO INC5 citations63